Search: „100% Pass Quiz IIA - Pass-Sure IIA-CIA-Part3 - Business Knowledge for Internal Auditing Valid Braindumps Free 📊 Simply search for 【 IIA-CIA-Part3 】 for free download on ▷ www.pdfvce.com ◁ 🤨IIA-CIA-Part3 Pdf Dumps“

Press
24. June 2013

evocatal draws two new investors as it closes €3.5m Series B round

evocatal GmbH has completed a Series B financing round. All of the company’s existing investors took part, along with new investors NRW.BANK and LANXESS. In realizing the next step of its growth strategy, Düsseldorf-based enzyme specialist evocatal has partnered with two new investors: specialty chemicals company LANXESS and the NRW.BANK. The investments from this round of financing will be used to extend the firm’s technology platform as well as its product portfolio. “We will signifi
 
Portfolio
26. January 2015

bookingkit

bookingkit offers a SaaS-solution tailored specifically to the activity industry. Due to an automatic booking process and a simple administration the workload of the vendor is reduced to a minimum. At the same time their sales are rising – due to higher booking numbers on the company’s own website and the promotion of their experiences via our connected marketing- and sales channels. The intelligent software of bookingkit manages the entire inventory of an activity provider, all incoming boo
 
Press
17. November 2012

Fliplife receives seven-digit investment for further product development and growth

Lead investor Mountain Super Angel and United Prototype Ventures support the ambitious Cologne-based browser game startup; previous investors High-Tech Gründerfonds and RapidShare Entertainment also reinvest. Fliplife is a product of UP Web Game GmbH, which was founded in late 2009 by Ibrahim Evsan, Thomas Bachem and Tobias Hartmann. The company develops and publishes Fliplife as a life simulation in a contemporary, realistic setting with comprehensive social features. Players can choose fro
 
Press
2. July 2024

DKFZ spin-off Epignostix raises €4.3m Seed round to commercialize diagnostic tumor classifier

Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification. CARMA FUND I Capital GmbH & Co KG led the round with participation from High-Tech Gründerfonds, LBBW Venture Capital GmbH and Start-up BW Seed Fonds. Heidelberg Epignostix’ technol
 
Press
7. July 2009

antispameurope closes additional funding round

Neuhaus Partners and High-Tech Gründerfonds have increased their shares in antispameurope. The inflow of additional capital is expected to further strengthen international growth of the Hannover based provider of managed e-mail security services. Both companies are investors into antispameurope since its first financing round in the fall of 2007. A second financing round was conducted in April of 2008. Dr. Gottfried Neuhaus, Managing Partner of Neuhaus Partners, appears pleased with the develo
 
Press
16. October 2009

High-Tech Gründerfonds Invests in Click-2-Call, the Next Generation of VoIP Technology

C2Call (Click-to-call) GmbH, a developer of a ground-breaking new Voice over Internet Protocol (VoIP) technology has received start up venture capital from High-Tech Gründerfonds and angel investors Michael Brehm – former executive director of StudiVZ – and Tapesh Sinha – Founder of Acctel Group. This investment will fund the internationalization and marketing of www.friendcaller.com, the world’s first Java browser-based VoIP suite and the popular FriendCaller iPhone apps. Developers o
 
Press
21. January 2020

HepaRegeniX GmbH secures Series B Financing in excess of €11 Mio. to advance first drug candidate to the clinic

Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models. HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases today announced the closing of its Series B financing round in excess of €11 Mio. with contribution from all its existing investors namely Boehringer Ingelheim Venture Fund GmbH (BIVF), Novo Holdings A/S, the High-Tech Gründerfonds,
 
Press
12. November 2019

Qnami Closes CHF 2.6M Seed Financing Round

Qnami announced today the closing of a CHF 2.6M (USD 2.6M) seed round led by Venture Capital fund Quantonation and further supported by investiere, ZKB Start-up Finance and the High-Tech Gründerfonds. The funds will support the market entry of Qnami’s first product, a quantum microscope for inspection of magnetic materials at the nanoscale, and further developments of quantum sensing applications. Qnami is a Swiss start-up founded in November 2017. It has developed an innovative platform for
 
Portfolio
17. June 2020

LOEWI (Exit)

LOEWI GmbH is a scientific spin-off of the TU München with the mission to make personalized health and nutrition available to everyone by combining science and technology. LOEWI's patented personalization concept analyzes health relevant data of customers and patients, makes the analysis available via LOEWI's Health Profile (Medical Software Class I), and creates personalized nutrient recommendations and therapies using a sophisticated recommendation algorithm, which are 100% tailored to the pe
 
Press
19. November 2019

Berlin-based startup Datarade raises €1m seed investment from HTGF to help companies source external data more efficiently

High-Tech Gründerfonds (HTGF) invests EUR 1 million in Datarade GmbH. Datarade is building a platform for companies to discover, compare and connect with already over 1,500 data providers across the globe. The invested capital will be used to grow the team in Berlin to further develop the platform. Companies increasingly use external data sources to fuel their analytics and predictions about their customers, markets and risks. But finding the right data sources amongst thousands of data provid
 
Press release - Guido Schlitzer neuer Geschäftsführer
Press
26. May 2020

High-Tech Gründerfonds appoints new Managing Director from its own ranks

Guido Schlitzer is to become Managing Director of High-Tech Gründerfonds Management GmbH effective 1 June, 2020, after having been appointed to the position by HTGF’s investor advisory board. In his current role as Chief Financial Officer, Schlitzer has been an integral part of the company’s success. The 47-year-old succeeds Dr. Michael Brandkamp, who left the company in late 2019 to set up the European Circular Bioeconomy Fund. Schlitzer will head up High-Tech Gründerfonds alongsi
 
Press
15. January 2020

Biograil secures seed funding for oral delivery device with potential to transform market for injectables

Biograil ApS, an innovative biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected, today announced the closing of a seed funding of 3 Million Euro (with potential to expand to 5 Million Euro). The investor Syndicate was led by the experienced German seed investor High-Tech Gründerfonds (HTGF) and included Danish Megatrend Invest a/s, Swiss Investment group as well as a Danish private healthcare investor. The device is being developed a
 
Press
25. February 2019

Frankfurt blockchain start-up Agora Innovation secures high six-figure investment from High-Tech Gründerfonds

High-Tech Gründerfonds invests high six-figure sum in Frankfurt Blockchain start-up Agora Innovation GmbH Frankfurt based fintech Agora Innovation develops software for legally compliant transactions on the blockchain   The Frankfurt based fintech Agora Innovation secures seed investment from High-Tech Gründerfonds (HTGF): The blockchain start-up develops a platform-independent software, which enables global, legally compliant trading of tokenized securities (security token) with
 
Press
23. January 2020

CereGate GmbH receives financing from High-Tech Gründerfonds to accelerate development of a new software platform for neuromodulation therapy

CereGate enables “Mind-Writing”, i.e. it directly transmits information to the brain The CereGate system is successfully validated in a clinical study Study results are currently presented during the NANS-Meeting in Las Vegas High-Tech Gründerfonds enters with a capital increase and convertible The financing shall accelerate development of the system for new indications in stroke rehabilitation, neuroprosthetics and computer/brain-interfacing   According to WHO more than 1
 
Press
26. April 2021

PreComb Therapeutics AG secures CHF 2.2 Mio seed financing to advance personalized medicine for cancer patients

PreComb develops the next generation point-of-care technology for patient-specific profiling of cancer therapies PreComb Therapeutics today announced the successful completion of the seed financing round led by Kinled Austria, the High-Tech Gründerfonds and FiveT capital, in addition to participations from other investors. Patrick Aisher, managing partner at Kinled Austria, joined the company’s board of directors. The seed funding will help advance the proprietary 3D3 Technol
 
Press
23. January 2020

Industry and SMEs meet innovation and start-ups

For the eleventh time, the High-Tech Partnering Conference (HTPC) will bring together industry and SMEs with innovation and financing experts More than 300 participants and more than 150 high-tech start-ups from sectors such as software, chemistry, healthcare, mechanical engineering and energy are expected to attend the High-Tech Gründerfonds (HTGF) event on 28 January 2020 Expert workshops are held on topics such as New Work, Security Token Offerings, IoT or Accelerators Inspirational